PhageNova Bio, Inc.
PrivateCompany Overview
PhageNova Bio, Inc. is a biotechnology company that develops a gene-therapy-based platform combining bacteriophage targeting with adeno-associated virus gene expression for cancer and vaccine applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
gene deliveryAAVPadeno-associated virusbacteriophagetargeted therapygene therapyoncologyvaccine platformvector platformsolid tumorsbiotechdrug discoveryprecision medicinephage therapyviral vector
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhageNova Bio, Inc. Comparables
Compare PhageNova Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siren Biotechnology | 82% | |
| LyseNTech | 72% | |
| Coastar Therapeutics | 72% | |
PhageNova Bio, Inc. Funding Rounds
Historical fundraising activity
PhageNova Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PhageNova Bio, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersSummit, New Jersey
Employee Range1
Year Founded2012
Last Funding—
See something wrong or outdated?